These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35956107)

  • 1. Liver Function Tests in COVID-19: Assessment of the Actual Prognostic Value.
    Tokarczyk U; Kaliszewski K; Kopszak A; Nowak Ł; Sutkowska-Stępień K; Sroczyński M; Sępek M; Dudek A; Diakowska D; Trocha M; Gajecki D; Gawryś J; Matys T; Maciejiczek J; Kozub V; Szalast R; Madziarski M; Zubkiewicz-Zarębska A; Letachowicz K; Kiliś-Pstrusińska K; Matera-Witkiewicz A; Pomorski M; Protasiewicz M; Sokołowski J; Adamik B; Kujawa K; Doroszko A; Madziarska K; Jankowska EA
    J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19.
    Lv Y; Zhao X; Wang Y; Zhu J; Ma C; Feng X; Ma Y; Zheng Y; Yang L; Han G; Xie H
    Front Med (Lausanne); 2021; 8():639855. PubMed ID: 34179034
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
    Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
    World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
    Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
    BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical predictors for Sars-Cov-2 severity.
    Gurusamy E; Mahalakshmi S; Kaarthikeyan G; Ramadevi K; Arumugam P; Gayathri MS
    Bioinformation; 2021; 17(9):834-839. PubMed ID: 35539890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.
    Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T
    Liver Int; 2022 Jun; 42(6):1297-1307. PubMed ID: 35412018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
    Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
    Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19?
    Kodavoor Vadiraj P; Thareja S; Raman N; Karantha SC; Jayaraman M; Vardhan V
    J Clin Exp Hepatol; 2022; 12(4):1114-1123. PubMed ID: 35125781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study.
    Xu W; Huang C; Fei L; Li Q; Chen L
    Clin Interv Aging; 2021; 16():675-685. PubMed ID: 33911856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of liver function changes in 111 elderly patients with COVID-19 pneumonia].
    Xu L; Zhu B; Liang BY; Liu J; Lu SS; Li SM; Zheng X
    Zhonghua Gan Zang Bing Za Zhi; 2022 May; 30(5):527-533. PubMed ID: 35764545
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization.
    Bernal-Monterde V; Casas-Deza D; Letona-Giménez L; de la Llama-Celis N; Calmarza P; Sierra-Gabarda O; Betoré-Glaria E; Martínez-de Lagos M; Martínez-Barredo L; Espinosa-Pérez M; M Arbones-Mainar J
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32899640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte-C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission.
    Zhang JN; Gao Y; Wang XT; Li NN; Du X; Tang YJ; Lai QQ; Chen PF; Yue CS; Wu JH; Kang K; Zhao MY
    Front Immunol; 2022; 13():957407. PubMed ID: 36248811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
    Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury.
    Lin Y; Yuan J; Long Q; Hu J; Deng H; Zhao Z; Chen J; Lu M; Huang A
    Genes Dis; 2021 Jul; 8(4):484-492. PubMed ID: 33225036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.
    Lei F; Liu YM; Zhou F; Qin JJ; Zhang P; Zhu L; Zhang XJ; Cai J; Lin L; Ouyang S; Wang X; Yang C; Cheng X; Liu W; Li H; Xie J; Wu B; Luo H; Xiao F; Chen J; Tao L; Cheng G; She ZG; Zhou J; Wang H; Lin J; Luo P; Fu S; Zhou J; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu L; Chen G; Li H; Huang X; Zhang BH; Yuan Y
    Hepatology; 2020 Aug; 72(2):389-398. PubMed ID: 32359177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain.
    Benedé-Ubieto R; Estévez-Vázquez O; Flores-Perojo V; Macías-Rodríguez RU; Ruiz-Margáin A; Martínez-Naves E; Regueiro JR; Ávila MA; Trautwein C; Bañares R; Bosch J; Cubero FJ; Nevzorova YA
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33802486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Nonalcoholic Fatty Liver Disease (NAFLD) on COVID-19: A Single-Center Study of 3983 Patients With Review of Literature.
    Nath P; Kumar R; Mallick B; Das S; Anand A; Panigrahi SC; Duseja A; Acharya SK; Chawla YK; Praharaj DL
    Cureus; 2022 Jul; 14(7):e26683. PubMed ID: 35949776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in liver function tests among patients hospitalized for COVID-19: a multicentric study in Peru.
    Marín-Dueñas I; Vega J; Carrillo-Ng H; Veramendi-Schult I; Zavaleta-Alva R; Vásquez-Elera L; Gonzales-Soler Z; Agurto HS; Tarrillo-Purisaca J; Garavito-Rentería J; Lozano-Miranda A
    Rev Gastroenterol Peru; 2021; 41(2):86-93. PubMed ID: 34724689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.